Biomea Fusion

Price & Volume

Stats

Open	$2.82
Previous Close	$2.79
Day Range	$2.65-$2.83
52W Range	$2.34-$16.29
Market Cap	$101.1M
Shares Short	11M

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$0
Diluted EPS	-$4.01

News

Yahoo Finance • 2 days ago

Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide Levels 3 Months After Last Dose

Yahoo Finance • 23 days ago

Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Yahoo Finance • last year

Biomea Fusion Announces Acceptance of Three Abstracts for its Novel Menin Inhibitor Highlighting Durable Glycemic Control in Diabetes Patients at the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in 2024

Yahoo Finance • last year

Biomea Fusion Abstract “BMF-219: A Novel Therapeutic Agent to Reestablish Functional Beta Cells and Provide Long-term Glycemic Control" Selected as One of Six Oral Presentations at 21st World Congress Insulin Resistance, Diabetes & Cardiovascular Disease

About

CEO	Mr. Thomas Andrew Butler
Address	900 Middlefield Road, Redwood City, CA, United States, 94063
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	107